Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs Based on Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Based on Viral
1.2.3 Based on Non-viral
1.3 Market by Application
1.3.1 Global Drugs Based on Gene Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs Based on Gene Therapy Market Perspective (2018-2029)
2.2 Drugs Based on Gene Therapy Growth Trends by Region
2.2.1 Global Drugs Based on Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drugs Based on Gene Therapy Historic Market Size by Region (2018-2024)
2.2.3 Drugs Based on Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Drugs Based on Gene Therapy Market Dynamics
2.3.1 Drugs Based on Gene Therapy Industry Trends
2.3.2 Drugs Based on Gene Therapy Market Drivers
2.3.3 Drugs Based on Gene Therapy Market Challenges
2.3.4 Drugs Based on Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs Based on Gene Therapy Players by Revenue
3.1.1 Global Top Drugs Based on Gene Therapy Players by Revenue (2018-2024)
3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Drugs Based on Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs Based on Gene Therapy Revenue
3.4 Global Drugs Based on Gene Therapy Market Concentration Ratio
3.4.1 Global Drugs Based on Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs Based on Gene Therapy Revenue in 2022
3.5 Drugs Based on Gene Therapy Key Players Head office and Area Served
3.6 Key Players Drugs Based on Gene Therapy Product Solution and Service
3.7 Date of Enter into Drugs Based on Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs Based on Gene Therapy Breakdown Data by Type
4.1 Global Drugs Based on Gene Therapy Historic Market Size by Type (2018-2024)
4.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Drugs Based on Gene Therapy Breakdown Data by Application
5.1 Global Drugs Based on Gene Therapy Historic Market Size by Application (2018-2024)
5.2 Global Drugs Based on Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drugs Based on Gene Therapy Market Size (2018-2029)
6.2 North America Drugs Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drugs Based on Gene Therapy Market Size by Country (2018-2024)
6.4 North America Drugs Based on Gene Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs Based on Gene Therapy Market Size (2018-2029)
7.2 Europe Drugs Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drugs Based on Gene Therapy Market Size by Country (2018-2024)
7.4 Europe Drugs Based on Gene Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs Based on Gene Therapy Market Size (2018-2029)
8.2 Asia-Pacific Drugs Based on Gene Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2018-2024)
8.4 Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs Based on Gene Therapy Market Size (2018-2029)
9.2 Latin America Drugs Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drugs Based on Gene Therapy Market Size by Country (2018-2024)
9.4 Latin America Drugs Based on Gene Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs Based on Gene Therapy Market Size (2018-2029)
10.2 Middle East & Africa Drugs Based on Gene Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2018-2024)
10.4 Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Drugs Based on Gene Therapy Introduction
11.1.4 Biogen Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Drugs Based on Gene Therapy Introduction
11.2.4 Novartis Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Drugs Based on Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Drugs Based on Gene Therapy Introduction
11.6.4 Amgen Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Introduction
11.7.4 Spark Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.8.5 Akcea Therapeutics Recent Development
11.9 Bluebird bio
11.9.1 Bluebird bio Company Detail
11.9.2 Bluebird bio Business Overview
11.9.3 Bluebird bio Drugs Based on Gene Therapy Introduction
11.9.4 Bluebird bio Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.9.5 Bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Detail
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Drugs Based on Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Detail
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Drugs Based on Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Detail
11.12.2 AnGes Business Overview
11.12.3 AnGes Drugs Based on Gene Therapy Introduction
11.12.4 AnGes Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Detail
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Detail
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Drugs Based on Gene Therapy Business (2018-2024)
11.14.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drugs Based on Gene Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Based on Viral
Table 3. Key Players of Based on Non-viral
Table 4. Global Drugs Based on Gene Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drugs Based on Gene Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drugs Based on Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drugs Based on Gene Therapy Market Share by Region (2018-2024)
Table 8. Global Drugs Based on Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drugs Based on Gene Therapy Market Share by Region (2024-2029)
Table 10. Drugs Based on Gene Therapy Market Trends
Table 11. Drugs Based on Gene Therapy Market Drivers
Table 12. Drugs Based on Gene Therapy Market Challenges
Table 13. Drugs Based on Gene Therapy Market Restraints
Table 14. Global Drugs Based on Gene Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drugs Based on Gene Therapy Market Share by Players (2018-2024)
Table 16. Global Top Drugs Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on Gene Therapy as of 2022)
Table 17. Ranking of Global Top Drugs Based on Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drugs Based on Gene Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drugs Based on Gene Therapy Product Solution and Service
Table 21. Date of Enter into Drugs Based on Gene Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs Based on Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drugs Based on Gene Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Drugs Based on Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drugs Based on Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Drugs Based on Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drugs Based on Gene Therapy Revenue Market Share by Application (2018-2024)
Table 29. Global Drugs Based on Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drugs Based on Gene Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America Drugs Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drugs Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drugs Based on Gene Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Drugs Based on Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drugs Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drugs Based on Gene Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Drugs Based on Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Drugs Based on Gene Therapy Product
Table 49. Biogen Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Drugs Based on Gene Therapy Product
Table 54. Novartis Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Drugs Based on Gene Therapy Product
Table 59. Gilead Sciences Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Drugs Based on Gene Therapy Product
Table 64. Sarepta Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product
Table 69. Alnylam Pharmaceuticals Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Drugs Based on Gene Therapy Product
Table 74. Amgen Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Drugs Based on Gene Therapy Product
Table 79. Spark Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Drugs Based on Gene Therapy Product
Table 84. Akcea Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. Bluebird bio Company Detail
Table 87. Bluebird bio Business Overview
Table 88. Bluebird bio Drugs Based on Gene Therapy Product
Table 89. Bluebird bio Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 90. Bluebird bio Recent Development
Table 91. Sunway Biotech Company Detail
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Drugs Based on Gene Therapy Product
Table 94. Sunway Biotech Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Detail
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Drugs Based on Gene Therapy Product
Table 99. SIBIONO Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Detail
Table 102. AnGes Business Overview
Table 103. AnGes Drugs Based on Gene Therapy Product
Table 104. AnGes Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Detail
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Drugs Based on Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Detail
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Drugs Based on Gene Therapy Product
Table 114. Human Stem Cells Institute Revenue in Drugs Based on Gene Therapy Business (2018-2024) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs Based on Gene Therapy Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Drugs Based on Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Based on Viral Features
Figure 4. Based on Non-viral Features
Figure 5. Global Drugs Based on Gene Therapy Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Drugs Based on Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Drugs Based on Gene Therapy Report Years Considered
Figure 11. Global Drugs Based on Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Drugs Based on Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Drugs Based on Gene Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Drugs Based on Gene Therapy Market Share by Players in 2022
Figure 15. Global Top Drugs Based on Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs Based on Gene Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drugs Based on Gene Therapy Revenue in 2022
Figure 17. North America Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 19. United States Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 23. Germany Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Drugs Based on Gene Therapy Market Share by Region (2018-2029)
Figure 31. China Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 39. Mexico Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Drugs Based on Gene Therapy Market Share by Country (2018-2029)
Figure 43. Turkey Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Drugs Based on Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 46. Novartis Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 47. Gilead Sciences Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 50. Amgen Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 51. Spark Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 53. Bluebird bio Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 54. Sunway Biotech Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 55. SIBIONO Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 56. AnGes Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 57. Orchard Therapeutics Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 58. Human Stem Cells Institute Revenue Growth Rate in Drugs Based on Gene Therapy Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed